23andMe Reports Q1 Revenue Drop, Narrows Lossesby Mark Eisenberg 10.08.202423andMe's Q1 revenue declines by 34% but narrows losses. Focus on AI and genetic studies drives future growth.
Microvast’s Q2 2024 Revenue Surges to $83.7Mby Mark Eisenberg 10.08.2024Microvast reports record Q2 2024 revenue at $83.7M, up 12%. Gross margin hits 32.5% amid EMEA sales boost, despite challenges.
Bruker Reports 17.4% Revenue Growth in Q2 2024by Mark Eisenberg 10.08.2024Bruker sees strong growth in Q2 2024, with strategic acquisitions boosting revenues despite challenges in biopharma and Chinese markets.
Honest Company Expands with Walmart, Boosts Revenue Outlookby Mark Eisenberg 10.08.2024Honest Company aims for mid to high-single digit growth, expanding in Walmart and enhancing e-commerce with new product launches.
Helios Fairfax Reports Q2 2024 Financial Resultsby Mark Eisenberg 10.08.2024Helios Fairfax sees strong investment performance despite a net loss of $16.5 million in Q2 2024, driven by unrealized losses.
Insulet Stock Drops Amid User Growth Concernsby Mark Eisenberg 10.08.2024Insulet's stock fell 8.8% despite raised revenue guidance, amid concerns over slowing user growth.
Organogenesis Q2 Revenue Surpasses Forecasts at $130Mby Mark Eisenberg 10.08.2024Organogenesis exceeds Q2 revenue expectations at $130.2M, driven by robust sales and strategic growth plans.
Floki Partners with Sunderland AFC, Eyes Major Growthby John Darbie 10.08.2024Floki teams up with Sunderland AFC aiming to boost adoption. Traders see a potential bull run, showcasing Floki’s Valhalla game.
Outbrain’s Q2 Success and Teads Acquisition Drive Growthby Mark Eisenberg 10.08.2024Outbrain's strong Q2 results and Teads acquisition set the stage for future growth and market leadership in online advertising.
French Economy Sees 0.35% Q3 Growth from Olympic Boostby Mark Eisenberg 10.08.2024France's economy is projected to grow 0.35% in Q3, aided by Olympic-related activities, says the central bank.